A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)

Clinical trial NCT02230566 · COMPLETED

Trial details

NCT number: NCT02230566
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

MPS 7 Sly Syndrome Mucopolysaccharidosis MPS VII

Start date: 2014-12-01
Primary completion: 2016-05-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.